Antimicrobial activity and pharmacokinetics/pharmacodynamics of the novel glycylcycline, tigecycline

Diagnostic Microbiology and Infectious Disease

Volumn 52, Issue 3, 2005, Pages 163-164

  Peterson, Lance R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GLYCYLCYCLINE DERIVATIVE; TIGECYCLINE;

ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; BACTERIAL STRAIN; CONFERENCE PAPER; DRUG SCREENING; DRUG SENSITIVITY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EUROPE; IN VITRO STUDY; INFORMATION PROCESSING; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NORTH AMERICA; PATHOGENESIS; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 23644455506     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2005.06.011     Document Type: Conference Paper

References (11)

1. S.K. Bouchillon, D.J. Hoban, B.M. Johnson, J.L. Johnson, A. Hsiung, M.J. Dowzicky the Tigecycline Evaluation and Surveillance Trial (TEST) Group In vitro activity of tigecycline against 3,989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004) Diagn. Microbiol. Infect. Dis. 52 2005 173 179
2. T.R. Fritsche, P.A. Strabala, H.S. Sader, M.J. Dowzicky, and R.N. Jones Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates Diagn. Microbiol. Infect. Dis. 52 2005 209 213
3. T.R. Fritsche, H.S. Sader, M.G. Stilwell, M.J. Dowzicky, and R.N. Jones Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000 - 2004) Diagn. Microbiol. Infect. Dis. 52 2005 195 201
4. T.R. Fritsche, H.S. Sader, M.G. Stilwell, M.J. Dowzicky, and R.N. Jones Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia Diagn. Microbiol. Infect. Dis. 52 2005 187 193
5. D.J. Hoban, S.K. Bouchillon, B.M. Johnson, J.L. Johnson, M.J. Dowzicky the Tigecycline Evaluation and Surveillance Trial (TEST Program) Group In vitro activity of tigecycline against 6,792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004) Diagn. Microbiol. Infect. Dis. 52 2005 215 227
6. A.K. Meagher, P.G. Ambrose, T.H. Grasela, and E.J. Ellis-Grosse Pharmacokinetic/ pharmacodynamic profile for tigecycline - A new glycylcycline antimicrobial agent Diagn. Microbiol. Infect. Dis. 52 2005 165 171
7. A.E. Pop-Vicas, and E.M.C. D'Agata The rising influx of multidrug-resistant Gram-negative bacilli into a tertiary care hospital Clin. Infect. Dis. 40 2005 1792 1798
8. H.S. Sader, R.N. Jones, M.J. Dowzicky, and T.R. Fritsche Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit Diagn. Microbiol. Infect. Dis. 52 2005 203 208
9. H.S. Sader, R.N. Jones, M.G. Stilwell, M.J. Dowzicky, and T.R. Fritsche Tigecycline activity tested against 26,474 bloodstream infection isolates: A collection from six continents Diagn. Microbiol. Infect. Dis. 52 2005 181 186
10. T. Stevens, B. Johnson, S. Bouchillon, D. Hoban, B. Johnson, M. Dowzicky, and P. Bradford Microdilution testing methodology for tigecycline: Addition of a biocatalytic oxygen-reducing agent may be required in the absence of fresh media 2004 The American Society for Microbiology Washington, DC (Poster: 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, October 30-November 2, 2004)
11. Tygacil Product Insert 2005 Wyeth Pharmaceuticals Inc Philadelphia (PA) (June, 2005)